Lymphocyte Response Depressive Factor in Multiple Sclerosis
- 27 November 1971
- Vol. 4 (5786) , 529-532
- https://doi.org/10.1136/bmj.4.5786.529
Abstract
Normal serum contains a lymphocyte response depressive factor and this is more active against the lymphocytes of the blood from which the serum was obtained than against lymphocytes from a different normal blood. The suppressive factor is thus “tailor-made” to its own lymphocytes though cross-reactivity with other lymphocytes does occur. The significance of this is discussed. The suppressive factor has a higher titre in serum from patients with multiple sclerosis or other destructive neurological disease than in normal serum. This may be an instance of a general phenomenon in which lymphocyte sensitization is ordinarily accompanied by production of a suppressor factor able to damp down response so that this is controlled by an “acceleratorbrake” mechanism. The possibilities of imbalance in the pathogenesis of disease and therapeutic manipulation of the level of suppressor substance are briefly discussed.Keywords
This publication has 18 references indexed in Scilit:
- IS MATERNAL LYMPHOCYTE SENSITISATION PASSED TO THE CHILD ?The Lancet, 1971
- ROLE OF SOLUBLE LYMPHOCYTE MEDIATORS IN MALIGNANT-TUMOUR DESTRUCTIONThe Lancet, 1971
- Specific Lymphocyte Sensitization in Cancer: Is There a Common Antigen in Human Malignant Neoplasia?BMJ, 1971
- Lymphocyte Sensitization in SarcoidosisBMJ, 1971
- Demonstration of sensitized lymphocytes in blood.Journal of Clinical Pathology, 1971
- REDUCED LYMPHOCYTE TRANSFORMATION DUE TO A PLASMA FACTOR IN PATIENTS WITH ACTIVE SYPHILISThe Lancet, 1969
- LYMPHOCYTE TRANSFORMATION IN MULTIPLE SCLEROSIS: Inhibition of Unstimulated Thymidine Uptake by a Serum FactorThe Lancet, 1968
- Transformation of Human Lymphocytes: Inhibition by Homologous Alpha GlobulinScience, 1968
- Inhibition of Tuberculin-Induced Mitogenesis in Cultures of Lymphocytes from Tuberculous DonorsInternational Archives of Allergy and Immunology, 1966
- SOME BIOLOGICAL PROPERTIES OF A HIGHLY ACTIVE ENCEPHALITOGENIC FACTOR ISOLATED FROM HUMAN BRAINThe Lancet, 1963